Richard Gonzalez, AP Images
Senators again point to AbbVie as a poster child for reform. Only this time Dems are targeting a low, low tax rate
In the first 4 years after AbbVie split away from Abbott with its big cash cow Humira in tow back in 2013, the pharma giant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
